About Misonix
Misonix is a company based in Farmingdale (United States) founded in 1959 was acquired by Bioventus in July 2021. The company has 1,013 employees as of December 31, 2021. Misonix has completed 2 acquisitions, including Fibrasonics.com and Solsys Medical. Misonix offers products and services including BoneScalpel®, SonaStar®, SonicOne® O.R., and neXus®. Misonix operates in a competitive market with competitors including Monteris, TechsoMed, Neo, Alesi Surgical and Thermedical, among others.
- Headquarter Farmingdale, United States
- Employees 1013 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Misonix Inc
-
Annual Revenue
$74.02 M (USD)18as on Jun 30, 2021
-
Net Profit
-$14.47 M (USD)17as on Jun 30, 2021
-
EBITDA
-$11.04 M (USD)43as on Jun 30, 2021
-
Latest Funding Round
- Investors
-
Employee Count
1013
as on Dec 31, 2021
-
Investments & Acquisitions
Fibrasonics.com
& 1 more
-
Acquired by
Bioventus
(Jul 29, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Misonix
Misonix offers a comprehensive portfolio of products and services, including BoneScalpel®, SonaStar®, SonicOne® O.R., and neXus®.
Ultrasonic tool for precise bone cutting in surgeries.
Device for ultrasonic dissection in medical procedures.
Ultrasonic system for debridement and tissue management.
Support system for ultrasonic surgical applications.
People of Misonix
Unlock access to complete
Funding Insights of Misonix
Investors in Misonix
Misonix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bioventus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healing therapy products are manufactured for medical applications.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Misonix
Misonix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Fibrasonics.com and Solsys Medical.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Human skin allografts and dressings for wound care are supplied.
|
1999 | ||||
|
Manufacturer of ultrasonic surgery devices
|
0 |
Financial Statements - Misonix
Misonix Comparisons
Competitors of Misonix
Misonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Monteris, TechsoMed, Neo, Alesi Surgical and Thermedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MRI-guided laser ablation tools for neurosurgery are developed.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
|
| domain | founded_year | HQ Location |
Blockchain infrastructure is utilized for developing decentralized applications.
|
|
| domain | founded_year | HQ Location |
Portable unit to continuously clear surgical smoke from abdominal cavity during laparoscopic procedures and improve visibility
|
|
| domain | founded_year | HQ Location |
Thermal ablation therapy is developed for ventricular tachycardia treatment.
|
Frequently Asked Questions about Misonix
Misonix was founded in 1959.
Misonix is headquartered in Farmingdale, United States. It is registered at Farmingdale, New York, United States.
Stavros Vizirgianakis is the current CEO of Misonix.
As of Dec 31, 2021, the latest employee count at Misonix is 1,013.
Annual revenue of Misonix is $74.02M as on Jun 30, 2021.
Misonix specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery. Their product offering includes Misonix BoneScalpel - a novel surgical device that slices crystalline bone while leaving elastic soft tissues largely unaffected; Misonix SonicOne - an ultrasonic surgical debridement system; and SonaStar - a ultrasonic aspiration system.
Misonix offers BoneScalpel®, SonaStar®, SonicOne® O.R., and neXus®.
Misonix has made 2 acquisitions, including Fibrasonics.com, and Solsys Medical.
Misonix has 1 investor. Key investors include Bioventus.